Table 2 In‐hospital management according to GRACE risk score for patients presenting with an acute coronary syndrome.
| Unstable angina/NSTEMI | STEMI | |||||||
|---|---|---|---|---|---|---|---|---|
| Low risk | Medium risk | High risk | p Value | Low risk | Medium risk | High risk | p Value | |
| Number | 3944 | 5440 | 5704 | 4119 | 2623 | 2359 | ||
| Cardiac catheterisation | 2836 (72%) | 3689 (68%) | 2894 (51%) | <0.001 | 3236 (79%) | 1937 (74%) | 1342 (57%) | <0.001 |
| PCI | 1554 (40%) | 1907 (35%) | 1426 (25%) | <0.001 | 2466 (60%) | 1421 (54%) | 959 (41%) | 0.98 |
| CABG | 298 (7.6%) | 425 (7.9%) | 361 (6.4%) | 0.006 | 162 (4.0%) | 108 (4.2%) | 86 (3.7%) | 0.67 |
| Fibrinolytics | 113 (2.9%) | 103 (1.9%) | 108 (1.9%) | 0.001 | 1538 (38%) | 828 (32%) | 445 (19%) | <0.001 |
| Exercise tolerance test | 977 (25%) | 1205 (23%) | 915 (16%) | <0.001 | 807 (20%) | 414 (16%) | 238 (10%) | <0.001 |
| Echocardiography | 2096 (54%) | 2784 (52%) | 3250 (58%) | <0.001 | 2985 (74%) | 1982 (76%) | 1815 (78%) | 0.002 |
| In‐hospital drugs | ||||||||
| Aspirin | 3705 (94%) | 5080 (93%) | 5136 (90%) | <0.001 | 3948 (96%) | 2490 (95%) | 2147 (91%) | <0.001 |
| Thienopyridine | 2009 (52%) | 2627 (49%) | 2292 (41%) | <0.001 | 2543 (62%) | 1485 (57%) | 1013 (44%) | <0.001 |
| UFH | 1956 (50%) | 2496 (47%) | 2627 (47%) | 0.001 | 2552 (63%) | 1527 (59%) | 1280 (55%) | <0.001 |
| LMWH | 2263 (58%) | 3145 (58%) | 3160 (56%) | 0.016 | 2052 (50%) | 1447 (56%) | 1251 (54%) | <0.001 |
| GP IIb/IIIa inhibitor | 1008 (26%) | 1197 (22%) | 1002 (18%) | <0.001 | 1669 (41%) | 914 (35%) | 659 (28%) | 0.099 |
| ACE inhibitor | 2157 (55%) | 2911 (54%) | 3234 (57%) | 0.004 | 2796 (68%) | 1861 (71%) | 1589 (68%) | 0.01 |
| β blocker | 3352 (85%) | 4533 (84%) | 4251 (75%) | <0.001 | 3706 (90%) | 2217 (85%) | 1615 (69%) | <0.001 |
| Calcium antagonist | 1120 (29%) | 1745 (32%) | 1936 (34%) | <0.001 | 578 (14%) | 490 (19%) | 425 (18%) | <0.001 |
ACE, angiotensin‐converting enzyme; CABG, coronary artery bypass grafting; GP, glycoprotein; GRACE, Global Registry of Acute Coronary Events; LMWH, low molecular weight heparin; MI, myocardial infarction; NSTEMI, non‐ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction; UFH, unfractionated heparin.